Idarucizumab Reversal of Dabigatran in Patients with Acute Ischemic Stroke and Intracranial Hemorrhage: Comparison with Non-idarucizumab-Treated Patients

Frol, S; Sernec, LP; Hudnik, LK; Sabovic, M; Oblak, JP

Frol, S (corresponding author), Univ Med Ctr Ljubljana, Dept Vasc Neurol, Ljubljana, Slovenia.; Frol, S (corresponding author), Univ Ljubljana, Fac Med, Dept Neurol, Ljubljana, Slovenia.

CNS DRUGS, 2021; 35 (2): 233

Abstract

Background Idarucizumab reverses the anticoagulant dabigatran; it is recommended during intravenous thrombolysis treatment of dabigatran-treated patie......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索